A multi-state model approach for prediction in chronic myeloid leukaemia.

about

A multi-state model approach for prediction in chronic myeloid leukaemia.

Item

http://www.wikidata.org/entity/Q38419761

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

A multi-state model approach for prediction in chronic myeloid leukaemia.

@en

type

Item

label

A multi-state model approach for prediction in chronic myeloid leukaemia.

@en

prefLabel

A multi-state model approach for prediction in chronic myeloid leukaemia.

@en

P1476

A multi-state model approach for prediction in chronic myeloid leukaemia

@en

P2093

German CML Study Group

http://www.w3.org/2001/XMLSchema#string

Joerg Hasford

http://www.w3.org/2001/XMLSchema#string

Markus Pfirrmann

http://www.w3.org/2001/XMLSchema#string

Martin C Müller

http://www.w3.org/2001/XMLSchema#string

Rüdiger Hehlmann

http://www.w3.org/2001/XMLSchema#string

Verena S Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Analysing and interpreting competing risk data.

High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis.

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia.

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial

Tutorial in biostatistics: competing risks and multi-state models.

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Harmonization of molecular monitoring of CML therapy in Europe.

P304

919-927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-014-2246-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Lauseker

P577

2014-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25465231

http://www.w3.org/2001/XMLSchema#string

P921

leukemia